Close Menu

sarcoma

Liquid Biopsy Space Eyed by Precision for Medicine With Recent Acquisition

A recent study highlights the ability of the company's prognostic tool to detect levels of circulating tumor cells in angiosarcoma patients.

Validation results presented at the Association for Molecular Pathology meeting demonstrate that the test can be implemented clinically, replacing existing FISH and PCR assays.